Score Breakdown
Offering Ability
42
Cash Runway
0
Float Risk
40
Warrant Exposure
15
Convertible Debt
15
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for BLTE.
Market Data
Market Cap$5.78B
Shares Outstanding39.34M
Float18.48M
Cash$352.93M
DebtN/A
Short InterestN/A
Institutional Holdings
QoQ: ↑ 30.0% shares (2026Q1 vs prior)
77 institutional holders · 9.40M shares
#1
Darwin Global Management, Ltd.
3.06M shares
#2
Paradigm Biocapital Advisors LP
1.11M shares
#3
UBS Group AG
768.4K shares
+ 17 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest1.13M
Days to Cover6.7
% of Float6.1%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
xbrl
XBRL CONVERTIBLE
2020-12-31
4
INSIDER TRANSACTION
2026-04-16
4
INSIDER TRANSACTION
2026-04-13
4
INSIDER TRANSACTION
2026-04-13
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual BLTE Dilution Snapshot
Belite Bio, Inc (BLTE) has a DilutionScore of 29/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for BLTE: 4 on 2026-04-16; 4 on 2026-04-13; 4 on 2026-04-13.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: